Oncolytic measles viruses produced at different scales under serum‐free conditions-Reference-Cited by-同舟云学术

Oncolytic measles viruses produced at different scales under serum‐free conditions

Published:2015-03-13 Issue:4 Volume:15 Page:425-436
ISSN:1618-0240
Container-title:Engineering in Life Sciences
language:en
Short-container-title:Eng. Life Sci.

Author:

Weiss Katja¹,Gerstenberger Jarrid¹,Salzig Denise¹,Mühlebach Michael D.²,Cichutek Klaus³,Pörtner Ralf⁴,Czermak Peter¹⁵⁶

Affiliation:

1. Institute of Bioprocess Engineering and Pharmaceutical TechnologyMittelhessen University of Applied Sciences Giessen Germany

2. Oncolytic Measles Viruses and Vectored VaccinesPaul‐Ehrlich‐Institut Langen Germany

3. Division of Medical BiotechnologyPaul‐Ehrlich‐Institut Langen Germany

4. Institute of Bioprocess and Biosystems Engineering, Hamburg University of Technology Hamburg Germany

5. Department of Chemical EngineeringKansas State University Manhattan KS USA

6. Faculty of Biology and ChemistryJustus‐Liebig‐University of Giessen Germany

Funder

Hessen initiative for scientific and economic excellence (LOEWE-program)

Publisher

Wiley

Subject

Bioengineering,Environmental Engineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/elsc.201400165

Reference46 articles.

1. Measles: Not just a childhood rash

2. Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics

3. Adherens junction protein nectin‐4 (PVRL4) is the epithelial receptor for measles virus;Mühlebach M.;Nature,2011

4. Russel S. J. Fielding A. K. Peng K.‐W. Grote D. Method for limiting the growth of cancer cells using an attenuated measles virus. US Patent 7393527 B2 2010.

5. KEY PARAMETERS OF MEASLES VIRUS PRODUCTION FOR ONCOLYTIC VIROTHERAPY

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platforms, advances, and technical challenges in virus-like particles-based vaccines;Frontiers in Immunology;2023-02-09

2. Upstream Processing of Viral Therapeutics: From Host Cell Expansion to Virus Production;Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs);2023

3. A Combined Ultrafiltration/Diafiltration Process for the Purification of Oncolytic Measles Virus;Membranes;2022-01-18

4. Vero cell upstream bioprocess development for the production of viral vectors and vaccines;Biotechnology Advances;2020-11

5. Upstream and Downstream Processes for Viral Nanoplexes as Vaccines;Vaccine Delivery Technology;2020-09-22